Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer.
about
Loss of phosphatase and tensin homolog expression correlates with clinicopathological features of non-small cell lung cancer patients and its impact on survival: A systematic review and meta-analysis.A four-gene signature predicts survival in clear-cell renal-cell carcinomaIncreased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancerDNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer.Deletion of 8p is an independent prognostic parameter in prostate cancer.Deletion of 18q is a strong and independent prognostic feature in prostate cancerPTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort.Loss of heterozygosity on chromosome 16q increases relapse risk in Wilms' tumor: a meta-analysis.Association of PTEN expression with biochemical recurrence in prostate cancer: results based on previous reports.Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer.Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer.
P2860
Q33633647-3E25934C-D855-4C08-A360-DF00532EFF63Q37696203-C3454FA1-DC9C-4FF0-A220-994AB37A71E0Q38659673-E051AEAB-7545-42F6-A10D-2495F04C053CQ38774228-44C4D2CB-EA0E-4156-9EB5-2BE7222D51D2Q42043270-BF9672EC-DFDA-4D57-87C8-67AF55A30DA8Q42316509-18B875DF-0D9D-4F47-93F5-82E5FABF5208Q42371556-AE5AB843-CBC0-41F9-AC53-FA9EDF8CDB26Q42371655-1F7D55A7-403F-4C52-8AB6-4E6C04A4DB70Q47094262-3B079BB0-8F62-453C-8925-6C11CB6EF690Q47158122-B2F46624-F62A-49FC-8EF8-F8634EF1E6E8Q47193753-62B3B030-3CB9-49F1-9E61-ABFB1C2EB946Q52645860-86C0062B-73F0-47A1-992B-9F74527E8A01
P2860
Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Concurrent deletion of 16q23 a ...... ic feature in prostate cancer.
@en
type
label
Concurrent deletion of 16q23 a ...... ic feature in prostate cancer.
@en
prefLabel
Concurrent deletion of 16q23 a ...... ic feature in prostate cancer.
@en
P2093
P2860
P356
P1476
Concurrent deletion of 16q23 a ...... ic feature in prostate cancer.
@en
P2093
Frederic Runte
Guido Sauter
Hartwig Huland
Jazan Omari
Lisa Paustian
Margit Fisch
Maria Christina Tsourlakis
Markus Graefen
Martina Kluth
Meike Adam
P2860
P304
P356
10.1002/IJC.29613
P577
2015-05-22T00:00:00Z